Nanotoxicity of multifunctional unlike cobalt nanoparticles (UCoNPs) with repercussions towards apoptosis and necrosis at nanobio-interfaces

2021 ◽  
Vol 11 ◽  
Author(s):  
Rajiv Kumar ◽  
Bhupender S. Chhikara ◽  
Kiran Gulia ◽  
Mitrabasu Chhillar

: The development of multifunction nanoparticles proved their worth in the field of the discovery of drug/gene delivery, nanotheranostics (in-vivo imaging, coinciding diagnostics), in external healing intercessions, designing a nano-bio interface, and to do desired alterations in nanotherapeutic. Every so often, the cellular uptake of multifunctional unlike cobalt [Co, CoO, Co2(CO)8 and Co3O4] nanoparticles (UCoNPs) influenced cellular mechanics and initiated numerous repercussions (oxidative stress, tempted DNA damages, cyto-genotoxicity, and chromosomal damages), in pathways, routes and generate dysregulating factors in the biochemical transformations exceedingly. Unlike dimensions of UCoNPs-cell interfaces, their physical features (size, shape, shell structure, and surface chemistry), possessions on cell proliferation and differentiation are the vital whys and wherefores, which are hereby, specifically identified as the key causes responsible for nanotoxicity. In this review, the UCoNPs intricacies (cyto-genotoxicity, clastogenicity, and immunomodulatory), nanotoxicity, and associated repercussions have been highlighted and discussed. The interpretation of quantitative structure-activity relationships, chemical transformations, biological, and toxicological analysis are discussed. The concerns and influences of multifunctional UCoNPs on different cell mechanisms (mitochondria impermeability, hydrolysis of ATP, the concentration of Ca2+, impaired calcium clearance, defective autophagy, apoptosis, and necrosis), and interlinked properties (adhesion, motility, and internalisation dynamics, role in toxicity, surface hydrophilic and hydrophobicity, biokinetics and biomimetic behaviors of biochemical reactions) have been summarised. Various applications i.e. bio-imaging, cell labelling, gene delivery, enhanced chemical stability, and increased bio-compatibility are highlighted concerning apoptosis, necrosis, and nanobio-interfaces with suitable examples.

2006 ◽  
Vol 175 (4S) ◽  
pp. 323-324 ◽  
Author(s):  
Joseph Dall'era ◽  
Sweaty Koul ◽  
Jesse Mills ◽  
Jeremy Myers ◽  
Randall B. Meacham ◽  
...  

2020 ◽  
Vol 20 (11) ◽  
pp. 821-830
Author(s):  
Prasad Pofali ◽  
Adrita Mondal ◽  
Vaishali Londhe

Background: Current gene therapy vectors such as viral, non-viral, and bacterial vectors, which are used for cancer treatment, but there are certain safety concerns and stability issues of these conventional vectors. Exosomes are the vesicles of size 40-100 nm secreted from multivesicular bodies into the extracellular environment by most of the cell types in-vivo and in-vitro. As a natural nanocarrier, exosomes are immunologically inert, biocompatible, and can cross biological barriers like the blood-brain barrier, intestinal barrier, and placental barrier. Objective: This review focusses on the role of exosome as a carrier to efficiently deliver a gene for cancer treatment and diagnosis. The methods for loading of nucleic acids onto the exosomes, advantages of exosomes as a smart intercellular shuttle for gene delivery and therapeutic applications as a gene delivery vector for siRNA, miRNA and Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and also the limitations of exosomes as a gene carrier are all reviewed in this article. Methods: Mostly, electroporation and chemical transfection are used to prepare gene loaded exosomes. Results: Exosome-mediated delivery is highly promising and advantageous in comparison to the current delivery methods for systemic gene therapy. Targeted exosomes, loaded with therapeutic nucleic acids, can efficiently promote the reduction of tumor proliferation without any adverse effects. Conclusion: In the near future, exosomes can become an efficient gene carrier for delivery and a biomarker for the diagnosis and treatment of cancer.


2019 ◽  
Vol 21 (12) ◽  
Author(s):  
Kaori Koizumi ◽  
Hitomi Nakamura ◽  
Masumi Iijima ◽  
Takashi Matsuzaki ◽  
Masaharu Somiya ◽  
...  

FEBS Letters ◽  
2001 ◽  
Vol 504 (3) ◽  
pp. 99-103 ◽  
Author(s):  
Kenneth Lundstrom ◽  
Christophe Schweitzer ◽  
Daniel Rotmann ◽  
Danielle Hermann ◽  
Edith M. Schneider ◽  
...  

1972 ◽  
Vol 4 (2) ◽  
pp. 97-102 ◽  
Author(s):  
L.C. Mishra ◽  
A.S. Parmar ◽  
J.A.R. Mead

2009 ◽  
Vol 11 (2) ◽  
pp. 102-108 ◽  
Author(s):  
Mahmud Uzzaman ◽  
Gordon Keller ◽  
Isabelle M. Germano

2008 ◽  
Vol 144 (2) ◽  
pp. 239
Author(s):  
Changyi J. Chen ◽  
Hao Wang ◽  
Min Li ◽  
Uddalak Bharadwaj ◽  
Hong Mu ◽  
...  

Stroke ◽  
2004 ◽  
Vol 35 (8) ◽  
pp. 1968-1973 ◽  
Author(s):  
Shigeru Tanaka ◽  
Kazuo Kitagawa ◽  
Shiro Sugiura ◽  
Emi Matsuoka-Omura ◽  
Tsutomu Sasaki ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document